Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thymoma × Ramucirumab × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 16 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 3 Adenocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Lung Neoplasms 2 Adenocarcinoma Of Esophagus 2 Thymoma 1 Recurrence 1 Pancreatic Neoplasms 1 Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Locally Advanced Unresectable Gastric Adenocarcinoma 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Gastroesophageal Cancer 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Clinical Stage III Gastric Cancer AJCC v8 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1 Carcinoid Tumor 1 Brain Neoplasms 1 Advanced Gastric or EGJ Cancer 1 Advanced Gastric Cancer 1 Adenocarcinoma of the Oesophagus 1

Interventions

Cisplatin 5 Radiotherapy 4 Cyclophosphamide 4 pembrolizumab 3 Sunitinib 3 130-nm albumin-bound paclitaxel 3 selinexor 2 Thymectomy 2 Pemetrexed 2 Etoposide 2 Drug Therapy 2 Doxorubicin 2 Chemoradiotherapy 2 Carboplatin 2 zimberelimab 1 regorafenib 1 epacadostat 1 envafolimab 1 bosutinib 1 amrubicin 1 TP protocol 1 Ramucirumab 1 Radiotherapy, Adjuvant 1 Radiosurgery 1 Radiofrequency Ablation 1 Radiation Dose Hypofractionation 1 Psychiatric Rehabilitation 1 Prednisone 1 Prednisolone 1 Patient Comfort 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03921671 2024-05-29

RELEVENT

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡